NCT05576259

Brief Summary

Social anxiety is characterised by excessive fear of being negatively judged, embarrassed or humiliated during social interactions and is common with a lifetime prevalence of 12.1%. Cognitive behavioural therapy is the first line of treatment, but people may not seek treatment due to a number of factors including the discomfort experienced in seeking help, inconvenience, and the experience of psychotherapy itself. With Virtual Reality (VR), users can have increased control in how gradually they expose themselves to social situations. In studies of VR in people with specific phobias, 76% of people prefer VR exposure to in vivo exposure. There is emerging evidence for the use of VR in social phobia. oVRcome, is a self-help VRET for social anxiety symptoms and specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. This study will evaluate the effectiveness of the oVRcome social anxiety program for social anxiety symptoms. We hypothesize that oVRcome will reduce social anxiety symptom severity over a 6-week treatment period compared to waiting-list control

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 8, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

October 9, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

April 9, 2025

Status Verified

November 1, 2023

Enrollment Period

9 months

First QC Date

October 9, 2022

Last Update Submit

April 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Liebowitz social anxiety scale -self report (LSAS)

    Assesses the way that social phobia plays a role in participants life across a variety of situations. Higher scores indicate more severe symptoms. Min 0 Max 144

    Week 6

Secondary Outcomes (6)

  • Brief Fear of Negative Evaluation Scale

    week 0,6,12,18

  • Patient's Global Impressions of Improvement (PGI-I) scale

    Week 1,2,3,4,5,6,7,8,9,10,11,12,18

  • Patient Health Questionnaire - PHQ 9

    Week 0,6,12,18

  • Modified Gatineau Presence Questionnaire First item

    Week 4,5,6

  • Fast Motion Sickness Scale (FMS)

    Week 4,5,6

  • +1 more secondary outcomes

Study Arms (2)

Smartphone application (app) in combination with headset

EXPERIMENTAL

The intervention oVRcome is self-help VRET for social anxiety, that is delivered through a smartphone application (app) in combination with headset that holds the smartphone and uses 360º video. oVRcome includes 6 modules of psychoeducation, relaxation, mindfulness, cognitive techniques, exposure through VR, and a relapse prevention module which are aimed to be completed weekly.

Other: oVRcome phone app with headset

Waitlist

NO INTERVENTION

Participants in the waitlist condition will be offered the intervention directly after post-test.

Interventions

The intervention oVRcome is self-help VRET for social anxiety, that is delivered through a smartphone application (app) in combination with headset that holds the smartphone and uses 360º video. oVRcome includes 6 modules of psychoeducation, relaxation, mindfulness, cognitive techniques, exposure through VR, and a relapse prevention module which are aimed to be completed weekly.

Smartphone application (app) in combination with headset

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • are between 18-64 years old
  • have moderate (or higher) social anxiety disorder symptoms on Liebowitz social anxiety scale (\>60)
  • have access to a smart phone and internet
  • willing to participate in the research study and providing informed consent

You may not qualify if:

  • present with symptoms of severe depression or suicidality respectively as measured with the PHQ-9; total score \> 19, =3 on suicidality item
  • have insufficient knowledge of the English language
  • are under current treatment for social phobia or psychotropic medication (unless on stable dosage for the previous 3 months and no changes planned during the study period).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Otago

Christchurch, 8001, New Zealand

Location

Related Publications (1)

  • Lacey C, Frampton C, Beaglehole B. A self-guided virtual reality solution for social anxiety: Results from a randomized controlled study. J Psychiatr Res. 2024 Dec;180:333-339. doi: 10.1016/j.jpsychires.2024.10.032. Epub 2024 Nov 4.

Related Links

Study Officials

  • Cameron Lacey, PhD

    University of Otago, Christchurch

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2022

First Posted

October 12, 2022

Study Start

October 8, 2022

Primary Completion

July 1, 2023

Study Completion

November 1, 2023

Last Updated

April 9, 2025

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations